In patients with suspected metastatic disease, cross-sectional imaging with ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI) is critical. In the group of patients ...

Brain metastases are a common problem in patients with EGFR-mutated non-small cell lung cancer (NSCLC), occurring in about ...

MRI is particularly helpful in the patient with suspected diffuse metastatic disease in whom CT or US might underestimate tumor burden (Fig. 16). An additional scenario where MRI is useful is in ...

(A definitive diagnosis of Alzheimer’s is made by a pathological evaluation of brain tissue, which is almost never obtained while a person is alive.) What the MRI shows is a disease of the blood ...

Your treatment plan will depend on your tumors (size, number, location in the brain, and genetic characteristics); the extent of disease ... metastases, your doctor will most likely order an MRI ...

(A definitive diagnosis of Alzheimer’s is made by a pathological evaluation of brain tissue, which is almost never obtained while a person is alive.) What the MRI shows is a disease of the blood ...

More information: Annabel J. Sorby-Adams et al, Portable, low-field magnetic resonance imaging for evaluation of Alzheimer's disease, Nature Communications (2024). DOI: 10.1038/s41467-024-54972-x ...

(A definitive diagnosis of Alzheimer’s is made by a pathological evaluation of brain tissue, which is almost never obtained while a person is alive.) What the MRI shows is a disease of the blood ...

In the study, researchers found that in 98% of cases, the MRI-based machine learning system alone could accurately predict whether the patient had Alzheimer’s disease or not.